Antiviral Drugs Market Size, Share & Trends Report

Antiviral Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Application (HIV, Hepatitis, Herpes, Influenza), By Type (Branded, Generics), By Region, And Segment Forecasts, 2021 - 2028

  • Published Date: Oct, 2021
  • Base Year for Estimate: 2020
  • Report ID: GVR-1-68038-389-8
  • Format: Electronic (PDF)
  • Historical Data: 2017 - 2019
  • Number of Pages: 120

Market Segmentation

  • Drug Class Outlook (Revenue, USD Million, 2017 - 2028)
    • DNA Polymerase Inhibitors
    • Reverse Transcriptase Inhibitors
    • Protease Inhibitors
    • Neuraminidase Inhibitors
    • Others
  • Type Outlook (Revenue, USD Million, 2017 - 2028)
    • Branded
    • Generics
  • Application Outlook (Revenue, USD Million, 2017 - 2028)
    • HIV
    • Hepatitis
    • Herpes
    • Influenza
    • Others
  • Regional Outlook (Revenue, USD Million, 2017 - 2028)
    • North America
      • North America Antiviral Drugs Market, By Drug Class
        • DNA Polymerase Inhibitors
        • Reverse Transcriptase Inhibitors
        • Protease Inhibitors
        • Neuraminidase Inhibitors
        • Others
      • North America Antiviral Drugs Market, By Type
        • Branded
        • Generics
      • North America Antiviral Drugs Market, By Application
        • HIV
        • Hepatitis
        • Herpes
        • Influenza
        • Others
      • U.S
        • U.S Antiviral Drugs Market, By Drug Class
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • U.S Antiviral Drugs Market, By Type
          • Branded
          • Generics
        • U.S Antiviral Drugs Market, By Application
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • Canada
        • Canada Antiviral Drugs Market, By Drug Class
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Canada Antiviral Drugs Market, By Type
          • Branded
          • Generics
        • Canada Antiviral Drugs Market, By Application
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
    • Europe
      • Europe Antiviral Drugs Market, By Drug Class
        • DNA Polymerase Inhibitors
        • Reverse Transcriptase Inhibitors
        • Protease Inhibitors
        • Neuraminidase Inhibitors
        • Others
      • Europe Antiviral Drugs Market, By Type
        • Branded
        • Generics
      • Europe Antiviral Drugs Market, By Application
        • HIV
        • Hepatitis
        • Herpes
        • Influenza
        • Others
      • U.K.
        • U.K. Antiviral Drugs Market, By Drug Class
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • U.K. Antiviral Drugs Market, By Type
          • Branded
          • Generics
        • U.K. Antiviral Drugs Market, By Application
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • Germany
        • Germany Antiviral Drugs Market, By Drug Class
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Germany Antiviral Drugs Market, By Type
          • Branded
          • Generics
        • Germany Antiviral Drugs Market, By Application
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • France
        • France Antiviral Drugs Market, By Drug Class
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • France Antiviral Drugs Market, By Type
          • Branded
          • Generics
        • France Antiviral Drugs Market, By Application
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • Italy
        • Italy Antiviral Drugs Market, By Drug Class
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Italy Antiviral Drugs Market, By Type
          • Branded
          • Generics
        • Italy Antiviral Drugs Market, By Application
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • Spain
        • Spain Antiviral Drugs Market, By Drug Class
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Spain Antiviral Drugs Market, By Type
          • Branded
          • Generics
        • Spain Antiviral Drugs Market, By Application
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
    • Asia Pacific
      • Asia Pacific Antiviral Drugs Market, By Drug Class
        • DNA Polymerase Inhibitors
        • Reverse Transcriptase Inhibitors
        • Protease Inhibitors
        • Neuraminidase Inhibitors
        • Others
      • Asia Pacific Antiviral Drugs Market, By Type
        • Branded
        • Generics
      • Asia Pacific Antiviral Drugs Market, By Application
        • HIV
        • Hepatitis
        • Herpes
        • Influenza
        • Others
      • India
        • India Antiviral Drugs Market, By Drug Class
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • India Antiviral Drugs Market, By Type
          • Branded
          • Generics
        • India Antiviral Drugs Market, By Application
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • China
        • China Antiviral Drugs Market, By Drug Class
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • China Antiviral Drugs Market, By Type
          • Branded
          • Generics
        • China Antiviral Drugs Market, By Application
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • Japan
        • Japan Antiviral Drugs Market, By Drug Class
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Japan Antiviral Drugs Market, By Type
          • Branded
          • Generics
        • Japan Antiviral Drugs Market, By Application
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • Australia
        • Australia Antiviral Drugs Market, By Drug Class
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Australia Antiviral Drugs Market, By Type
          • Branded
          • Generics
        • Australia Antiviral Drugs Market, By Application
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • South Korea
        • South Korea Antiviral Drugs Market, By Drug Class
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • South Korea Antiviral Drugs Market, By Type
          • Branded
          • Generics
        • South Korea Antiviral Drugs Market, By Application
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
    • Latin America
      • Latin America Antiviral Drugs Market, By Drug Class
        • DNA Polymerase Inhibitors
        • Reverse Transcriptase Inhibitors
        • Protease Inhibitors
        • Neuraminidase Inhibitors
        • Others
      • Latin America Antiviral Drugs Market, By Type
        • Branded
        • Generics
      • Latin America Antiviral Drugs Market, By Application
        • HIV
        • Hepatitis
        • Herpes
        • Influenza
        • Others
      • Argentina
        • Argentina Antiviral Drugs Market, By Drug Class
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Argentina Antiviral Drugs Market, By Type
          • Branded
          • Generics
        • Argentina Antiviral Drugs Market, By Application
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • Brazil
        • Brazil Antiviral Drugs Market, By Drug Class
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Brazil Antiviral Drugs Market, By Type
          • Branded
          • Generics
        • Brazil Antiviral Drugs Market, By Application
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • Mexico
        • Mexico Antiviral Drugs Market, By Drug Class
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Mexico Antiviral Drugs Market, By Type
          • Branded
          • Generics
        • Mexico Antiviral Drugs Market, By Application
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • Colombia
        • Colombia Antiviral Drugs Market, By Drug Class
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Colombia Antiviral Drugs Market, By Type
          • Branded
          • Generics
        • Colombia Antiviral Drugs Market, By Application
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
    • Middle East & Africa
      • Middle East & Africa Antiviral Drugs Market, By Drug Class
        • DNA Polymerase Inhibitors
        • Reverse Transcriptase Inhibitors
        • Protease Inhibitors
        • Neuraminidase Inhibitors
        • Others
      • Middle East & Africa Antiviral Drugs Market, By Type
        • Branded
        • Generics
      • Middle East & Africa Antiviral Drugs Market, By Application
        • HIV
        • Hepatitis
        • Herpes
        • Influenza
        • Others
      • Saudi Arabia
        • Saudi Arabia Antiviral Drugs Market, By Drug Class
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • Saudi Arabia Antiviral Drugs Market, By Type
          • Branded
          • Generics
        • Saudi Arabia Antiviral Drugs Market, By Application
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • UAE
        • UAE Antiviral Drugs Market, By Drug Class
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • UAE Antiviral Drugs Market, By Type
          • Branded
          • Generics
        • UAE Antiviral Drugs Market, By Application
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others
      • South Africa
        • South Africa Antiviral Drugs Market, By Drug Class
          • DNA Polymerase Inhibitors
          • Reverse Transcriptase Inhibitors
          • Protease Inhibitors
          • Neuraminidase Inhibitors
          • Others
        • South Africa Antiviral Drugs Market, By Type
          • Branded
          • Generics
        • South Africa Antiviral Drugs Market, By Application
          • HIV
          • Hepatitis
          • Herpes
          • Influenza
          • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2017 to 2028
  • Market estimates and forecast for product segments up to 2028
  • Regional market size and forecast for product segments up to 2028
  • Market estimates and forecast for application segments up to 2028
  • Regional market size and forecast for application segments up to 2028
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.